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 ABSTRACT  
 Objectives  (1) To develop risk prediction models for 
knee osteoarthritis (OA) and (2) to estimate the risk 
reduction that results from modifi cation of potential risk 
factors. 
 Method  This was a 12-year retrospective cohort study 
undertaken in the general population in Nottingham, UK. 
Baseline risk factors were collected by questionnaire. 
Incident radiographic knee OA was defi ned by Kellgren 
and Lawrence (KL) score ≥2. Incident symptomatic knee 
OA was defi ned by KL ≥2 plus knee pain. Progression 
of knee OA was defi ned by KL ≥1 grade increase 
from baseline. A logistic regression model was used 
for prediction. Calibration and discrimination of the 
models were tested in the Osteoarthritis Initiative (OAI) 
population and Genetics of Osteoarthritis and Lifestyle 
(GOAL) population. ORs of the models were compared 
with those obtained from meta-analysis of existing 
literature. 
 Results  From a community sample of 424 people aged 
over 40, 3 risk prediction models were developed. These 
included incidence of radiographic knee OA, incidence of 
symptomatic knee OA and progression of knee OA. All 
models had good calibration and moderate discrimination 
power in OAI and GOAL. The ORs lied within the 95% 
CIs of the published studies. The risk reduction due to 
modifying obesity at the individual and the population 
levels were demonstrated. 
 Conclusions  Risk prediction of knee OA based on the 
well established, common modifi able risk factors has 
been established. The models may be used to predict the 
risk of knee OA, and risk reduction due to preventing a 
specifi c risk factor. 
 Knee osteoarthritis (OA) is the most common form 
of chronic joint disease and the leading cause of 
lower limb disability in older patients. 1 Although 
there are more than 50 treatments for symptom-
atic relief, the beneﬁ ts of these treatments are only 
marginal over placebo, 2 – 4 and often outweighed by 
their side effects. 2  4 Currently there is no effective 
treatment for structure modiﬁ cation. The majority 
of patients have to cope with the disease for most 
of their lives, and even of those who undergo total 
joint replacement, 6% to 30% still have persistent 
knee pain after the surgery. 5 – 8 At present, estab-
lished symptomatic OA is a chronic, disabling and 
incurable condition. 
 In contrast, research in the past two decades into 
the epidemiology of knee OA has identiﬁ ed oppor-
tunities for primary and secondary disease preven-
tion. 9 A number of risk factors for development of 
knee OA have been conﬁ rmed. 10 For the purpose 
of prevention, they may be classiﬁ ed into non-
 modiﬁ able (eg, age, gender, genetic susceptibility/ 
family history) and potentially modiﬁ able risk 
factors (eg, body mass index (BMI), occupational 
risk, joint injury, quadriceps weakness, nutrients, 
bone mineral density and oestrogen deﬁ ciency). 9 
Some new risk factors have been recently identi-
ﬁ ed such as the longer ring ﬁ nger (2D:4D ratio), 11   12 
varus/valgus mal-alignment 13  14 and genetic pre-
disposition 15  16 but many of these have yet to be 
ratiﬁ ed. 
 This project aimed to develop conventional risk 
prediction models for knee OA. The objectives 
were to: (1) establish (development and validation) 
risk prediction models for the development and 
progression of knee OA focusing on the conven-
tional and modiﬁ able risk factors and (2) estimate 
the risk reduction consequent upon successful 
modiﬁ cation of a single or multiple risk factors at 
the individual and population levels. To the best of 
our knowledge, such conventional risk prediction 
models, although well established in cardiovascular 
and cancer research, 17  18 have not been developed 
for OA. 
 METHODS 
 Development 
 Study design and setting 
 A 12-year retrospective cohort study was under-
taken involving four general practices in North 
Nottinghamshire. The study was approved by 
the Nottinghamshire County Primary Care Trust, 
Nottingham University Hospitals NHS Trust and 
the Nottingham Research Ethics Committee 1. 
 Participants 
 Individuals were recruited from two baseline 
community postal questionnaire studies for knee 
pain. 19  20 Baseline data were collected between 
1996 and 1999 from 9429 adults aged 40–79 on the 
general practice registers. A follow-up survey was 
undertaken during 2007–2008 in 5479 individuals 
who are still registered with the general practices 
and eligible for the study. People with terminal ill-
ness, psychiatric illness and severe dementia were 
excluded. Radiographs of both knees at baseline 
and follow-up were obtained from 424 participants 
according to availability and willingness to partici-
pate through informed, written consent. 
 Defi nitions of incident knee OA and progression 
 Baseline and follow-up tibiofemoral and patell-
ofemoral radiographs were taken using the same 
protocol (standing posteroanterior and skyline 
views) and scored by a single, experienced observer 
(SAD) as a single batch. Those with a Kellgren and 
Lawrence (KL) score 21 <2 for the tibiofemoral com-
partment and equivalent categories (ie, completely 
normal, possible osteophyte or doubtful narrow-
ing) for the patellofemoral compartment of both 
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knees at baseline and follow-up were deﬁ ned as non-OA. Those 
that satisﬁ ed the deﬁ nition of KL score ≥2 or equivalent for any 
compartment of any knee were deﬁ ned as knee OA. Participants 
with no knee OA at baseline, who had knee OA at follow-up 
were deﬁ ned as incident knee OA. Also, those with incident 
knee OA and concurrent knee pain were deﬁ ned as symptomatic 
knee OA. Those with knee OA at baseline and an increase of 1 
or more in KL score or equivalent at follow-up in any of their 
knee compartments were deﬁ ned as knee OA progression. 
 Risk prediction model 
 Logistic regression was used for each prediction: 22 
Logit=ln(p/1–p)=α+β1Xi+...+βiXi  (1)
 where p is the probability of the disease, α is the constant 
and β is the logarithm value of OR for a speciﬁ c predictor X i . For 
convenient prediction, we kept age and BMI as continuous vari-
ables and others as dichotomous or categorical variables. The 
logit operator maintains the linearity of the model and allows 
the calculation of a probability of disease given the different sets 
of predictors, according to 22 : 
p
it
it
e
e
=
+
log
log 1
 
(2)
 Selection of the predictors 
 For the purpose of the risk prediction and modiﬁ cation, we 
focused on well established conventional predictors age (years), 
gender (0=male, 1=female) and modiﬁ able predictors, such as, 
BMI (kg/m 2 ), occupational risks (0–4), previous knee injury 
(0=no, 1=yes) and familial OA (0=no, 1=yes). Occupational risk 
was scored retrospectively from work performed during the last 
12 years. We were particularly interested in occupational kneel-
ing and lifting; each of these was scored as 0=never, 1=seldom, 
2=sometimes, 3=often, 4=always and the highest value was 
taken. Familial OA was determined at follow-up and scored as 
positive if participants reported parents, siblings or grandparents 
having a diagnosis of OA, having undergone arthroplasty of the 
knee or hip, or if they were reported to have Heberden’s nodes 
(0=no, 1=yes). Knee injuries up to follow-up were included 
(0=no, 1=yes). Sport activity during the last 12 years was deﬁ ned 
as regular leisure activity such as golf, tennis, cricket, ballroom 
dancing, aerobics, hiking and walking, etc. Knee pain during the 
last 12 years was deﬁ ned as pain in or around a knee on most 
days for at least a month. Knee pain was not used as a predictor, 
but part of outcome measures for knee OA. 
 Validation 
 Calibration and discrimination 
 Calibration and discrimination abilities 17 of the models were 
examined in three populations: (1) the Nottingham knee OA ret-
rospective cohort study population (n=424); (2) the Nottingham 
Genetics of Osteoarthritis and Lifestyle (GOAL) case-control 
study population (n=3174) 11 and (3) the Osteoarthritis Initiative 
(OAI) cohort study population (n=4796). 23 
 Calibration assesses how closely the predicted probabilities 
reﬂ ect actual risk. A risk score was calculated for each individual 
using equation (1). The higher the risk score the greater the risk 
of disease. The individuals were classiﬁ ed into different groups 
(deciles) according to the risk scores. Observed and predicted 
frequencies of the disease in subgroups were calculated. The 
Hosmer–Lemeshow χ 2 statistics for goodness-of-ﬁ t were used 
for calibration to compare observed and predicted risk deciles; 
and small values indicate good calibration. 24 
 Discrimination examines the ability to correctly classify 
 subjects into different groups. To assess this parameter, the area 
under the receiver operating characteristic (ROC) curve was used. 
ROC presents a curve of sensitivity (y axis) against  1−speciﬁ city 
(x axis) at different cut-off points of the risk score. Larger values 
of the ROC indicate better discriminative power. 25 
 Systematic review 
 Systematic literature reviews and meta-analyses were under-
taken for three major modiﬁ able risk factors: BMI, 26 occupa-
tional risk 27 and knee injury. Data were extracted by at least two 
investigators and disagreements were discussed and ratiﬁ ed. The 
purposes of these reviews were: (1) to further validate the model 
estimate in the context of the general relative risk and 95% CI 
pooled from the literature and (2) to calculate risk reduction at 
the population level using pooled relative risk estimates. Pooled 
ORs from cohort studies were used for the comparison and the 
risk reduction estimation. 
 Risk reduction 
 The risk reduction was estimated for individuals using the mod-
els; and the populations using population attributable risk per-
centage (PAR%). PAR% is the proportion of people with knee 
OA that would have been avoided, should the risk factor(s) be 
modiﬁ ed. 9 It is calculated by PAR%=P e (OR−1)/(P e (OR − 1)+1) × 
100%, where P e is the prevalence of risk factor (eg, obesity), and 
OR is the odds ratio or relative risk of the disease associated 
with the risk factor. We used pooled OR from the systematic 
review of cohort studies to calculate the PAR%. 
 RESULTS 
 Population characteristics 
 Development 
 In total, 424 people participated in radiographic examinations 
at baseline and follow-up. The sample had mean age of 56.8 
years (SD 7.9), 64% women, mean BMI of 25.5 (SD 3.5) and 
56% people with knee pain. The sample was slightly younger 
and lighter, had more women and people with knee pain than 
the source population. 28 The median (IQR) time period of fol-
low-up was 12 years (7–12 years). Incident knee OA was seen 
in 55% (99/179) of patients and progression was found in 67% 
(75/112). 
 Validation 
 In addition to the internal population, two external populations 
were used for the model validation: OAI and GOAL. The char-
acteristics are compared in  table 1 . 
 Table 1  Comparison between internal and external groups 
  Internal  OAI  GOAL 
Study design Retrospective 
cohort
Cohort Case-control 
study
N 424 4796 3170
Age, mean±SD 56.8±7.9 61±9 66.6±7.9
BMI, mean±SD 25.5±3.5 28.6±4.8 29.3±5.3
Women, n 64% 42% 48%
Occupational risk median (IQR) 3 (2–4) 2 (1–3) 1 (1–3)
Percentage injury 12% 41% 22%
Percentage familial OA 32% 20% Not known
 Age and BMI presented as mean and SD. Occupational risk presented as median and 
IQR and others presented as percentage prevalence. Knee injury was defi ned in OAI as 
an injury that limited walking for at least 7 days. 
 BMI, body mass index; GOAL, Genetics of Osteoarthritis and Lifestyle; 
OA, osteoarthritis; OAI, Osteoarthritis Initiative. 
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 The OAI study is a community-based cohort study for knee 
OA in higher risk population. 23 For incident knee OA in OAI, 
doctor-diagnosed knee OA was used as the end point as radio-
graphic assessment had not yet been performed at follow-up. 
The OAI population we used for analyses contained 1489 people, 
and 162 were diagnosed as having knee OA during 36 months 
of follow-up. Kneeling, squatting and lifting at work were used 
to estimate occupational risk factors; and familial knee OA was 
estimated by relatives undergoing arthroplasty. The GOAL 
study was a hospital-based case-control study of low limb large 
joint OA. Participants had clinically severe knee OA sufﬁ cient to 
warrant consideration of total knee replacement (TKR) 11 ; GOAL 
had 1385 with knee OA (from the index knee OA and hip OA 
groups) and 1125 without knee OA (from the control and index 
hip OA groups). The assessment of risk factors in GOAL was 
broadly similar to the internal population. 
 Risk prediction models 
 Three risk prediction models have been developed, two for the 
incidence and one for the progression of knee OA: 
Incidence of radiographic OA (KL 1. ≥2) 
Logit= 7.542+0.055 age+0.2 female+0.105 
BMI+0.3 occupation
−
al risk+0.42 
family history+0.673 knee injury (model 1)
 Incidence of symptomatic knee OA (KL 2. ≥2 and current 
pain in the same knee) 
Logit= 7.733+0.056 age+0.029 female+0.089
BMI+0.245 occupat
−
ional risks+0.543 
family history+0.870 knee injury (model 2)
 Progression of knee OA (KL increased 3. ≥1 grade) 
 Logit=2.804 0.061 age 0.066 female+0.818 
knee injury+0.877
− −
 sports+0.435 
OA compartments (model 3)
 Deﬁ nitions of the predictors are illustrated in  table 2 . 
 Validation 
 Calibration 
 The Hosmer–Lemeshow χ 2 statistics for goodness-of-ﬁ t showed 
good calibration internally and externally for all three models 
( table 3 ). 
 Discrimination 
 The area under the ROC curve for internal cohort showed a 
moderate discriminative ability of model 1 (ROC 0.69, 95% 
CI 0.62 to 0.76). Similar but slightly better discriminative ability 
was seen for models 2 and 3 ( table 3 ). In the external popula-
tions, the models demonstrated moderate discriminative power 
to predict the incidence and progression of knee OA in the OAI 
population and stronger discriminative power to separate knee 
OA in the GOAL population ( ﬁ gure 1 ). 
 Comparison between the models and meta-analysis of other 
cohort studies 
 ORs for BMI, occupation risk and knee injury estimated from 
the model were compared with those obtained from the litera-
ture. The OR estimated from the model tended to be smaller 
than that from the published cohort studies, but the 95% CIs 
were overlapping ( table 4 ). 
 Risk reduction 
 Individual risk reduction 
 The risk reduction varied depending on the risk factor(s) to be 
modiﬁ ed. For example, a woman aged 50 with BMI 30, seldom 
kneeling/lifting, no family history of OA and no knee injury had 
a risk of 24% to develop knee OA in 12 years. By reducing BMI 
to 25, the risk would reduce to 16%. These may be calculated 
using equation (2). 
 Population risk reduction 
 Our systematic review showed that for obese individuals pooled 
OR for radiographic and symptomatic knee OA were 3.36 
(95% CI 2.74 to 4.13) and 3.98 (95% CI 2.77 to 5.71), respec-
tively. 26 These pooled estimates and country-speciﬁ c obesity 
 Table 2 Defi nition of predictors 
 Predictor  Defi nition  Model application 
Age Age in years Incidence and 
progression
Gender Female=1, male=0 Incidenc and 
progression
Body mass index kg/m 2 Incidence
Occupational risks Kneeling/lifting at work: 0=never, 
1=seldom, 2=sometimes, 
3=often, 4=always
Incidence
Family osteoarthritis First-degree relative with 
osteoarthritis, joint replacement, 
or fi nger nodes=1. None=0
Incidence
Knee injury Previous serious knee injury=1. 
No injury=0
Incidence and 
progression
Knee pain Pain in or around a knee on most 
days for at least a month=1, 
no knee pain=0
Progression
Sports Regular physical activity (eg, golf, 
tennis, cricket)=1, none=0
Progression
Number of knee 
compartments with 
osteoarthritis (OA)
Knee compartments with 
radiographic OA (1–4)
Progression
 Table 3  Validation of the risk prediction models 
 
 Calibration: Hosmer–Lemeshow χ  2   (p value)  Discrimination: ROC (95% CI) 
 Internal  OAI  GOAL  Internal  OAI  GOAL 
Incidence
 Model 1: radiographic knee OA  2.29 (0.971)  7.59 (0.576) 9.87 (0.362) 0.69 (0.62 to 0.76) 0.60 (0.55 to 0.64) 0.74 (0.72 to 0.76)
 Model 2: symptomatic knee OA 11.76 (0.162) 16.86 (0.051) 8.231 (0.511) 0.70 (0.61 to 0.79) 0.60 (0.58 to 0.63) 0.79 (0.77 to 0.81)
Progression
 Model 3: radiographic knee OA 12.01 (0.151) 11.66 (0.233) NA 0.71 (0.61 to 0.82) 0.52 (0.45 to 0.58) NA
 NA: models for knee OA progression could not be tested in the GOAL study due to its cross-sectional nature. 
 GOAL, Genetics of Osteoarthritis and Lifestyle; OA, osteoarthritis; OAI, Osteoarthritis Initiative; ROC, receiver operating characteristic. 
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prevalence 29 were used to calculate PAR% ( table 5 ), in the USA 
where the prevalence of obesity in the population is estimated 
at 34%, PAR% for radiographic and symptomatic knee OA was 
44% and 50%, respectively. 
 DISCUSSION 
 Several studies have claimed risk prediction models in OA 30 – 32 
but, apart from one examining blood levels of vascular cell 
adhesion molecule 1 as a predictor at baseline for total hip/knee 
replacement in 15 years, 30 all others in fact are not prediction but 
classiﬁ cation models of the disease. 31  32 This is the ﬁ rst study to 
develop risk prediction models in knee OA using conventional 
risk factors such as age, gender, family history, BMI, occupational 
risk and joint injury. The models were developed from a 12-year 
retrospective community cohort study, and therefore they are 
suitable for the general population. Two models for the incidence 
of radiographic and symptomatic knee OA, and one model for 
the progression of radiographic knee OA were developed. Knee 
pain was treated as part of the disease outcome, not a predictor 
to keep the models simple and easy to use. Further develop-
ment may be made in the future for the prediction model for 
the progression of symptomatic knee OA taking into account of 
knee pain and radiographic change at baseline. The models have 
been validated in three different populations with reasonable 
calibration and discriminative abilities. Better discrimination in 
the GOAL population, a hospital-based case-control study, sug-
gests that the models have good discrimination power between 
established hospital cases and controls. However, these are not 
classiﬁ cation models, and therefore should not be used for the 
purpose of the clinical diagnosis or classiﬁ cation of the disease. 
The latter should follow the established diagnostic algorithm 33 
or classiﬁ cation criteria 34 as appropriate. 
 The generalisability of the models has been further examined 
by comparing relative risk estimates with those obtained by 
meta-analysis of published literature. The smaller relative risk 
estimates derived from the models may be caused by adjust-
ments for multiple covariates and also population variations. 
 There are some differences between the incidence models 
(model 1 and 2) and the progression model (model 3). While 
age, gender, BMI, occupational exposure, family history and 
knee injury are the major positive predictors for the incidence 
of knee OA, number of compartments affected, knee injury and 
sport activities predict the progression. OA in older age and 
female gender is less likely to progress. BMI is not predictive 
for the progression (model 3). These suggest the aetiological 
differences between the development and the progression of 
knee OA. 
 Several differences between populations may affect the 
results of the validation. OAI is a rheumatology cohort study, 
which measured most of the predictors in a compatible way to 
the Nottingham cohort. The data from OAI are currently most 
suitable for validation of radiographic OA progression models, 
as baseline and follow-up radiographs for these patients have 
been assessed by the same research team as part of a single 
project. The follow-up radiographs in OAI for those without 
knee OA at baseline have not yet been assessed, and so we used 
self-reported doctor diagnosis of incident knee OA as our end 
point for validation purposes. OAI will assess them at a later 
time point and further validation will be undertaken once the 
data become available. In addition, OAI used a study population 
at high risk of knee OA and only measured tibiofemoral OA, 
whereas Nottingham measured tibiofemoral and patellofemo-
ral OA. GOAL is only suitable for classiﬁ cation, not prediction 
of the disease as it is a case-control study and the population 
was selected from hospital lists with clinically severe knee OA 
sufﬁ cient to warrant consideration of TKR. Population differ-
ences are always a potential problem for the risk prediction. It 
is therefore suggested that a validation/modiﬁ cation should be 
undertaken before applying any risk prediction model. 35 
 There are several limitations to this study. First, the inter-
nal cohort was small (424) and it was not a random sample of 
the general population. Participants were slightly younger and 
lighter, had more smokers and people with knee pain than the 
source population. Therefore this may limit the model’s gener-
alisability. Although we have undertaken multiple validations in 
different populations, further validation is required prior to the 
use of the Nottingham models. Second, only conventional pre-
dictors (such as age, gender, family history, BMI, occupational 
risk and knee injury) have been included. Many others such 
as quadriceps weakness, oestrogen deﬁ ciency, genetics or bio-
markers may be added. Third, several of the predictors from the 
internal cohort were measured retrospectively, by asking about 
the last 12 years of life. Occupation was assessed only during 
the last 12 years, whereas knee injury included all previous time. 
Family history of OA was self-reported and so open to recall or 
measurement bias. Fourth, the risk factors for tibiofemoral and 
patellofemoral OA are likely to differ. However, the size of this 
study was insufﬁ cient to discriminate between the two major 
sites of knee OA, without losing statistical power. Furthermore, 
BMI is the only risk factor that may be directly modiﬁ ed, others 
(occupational risk and injury) are theoretically modiﬁ able but 
practically difﬁ cult to change. Prevention or indirect modiﬁ cation 
 Table 4 Comparison of OR and 95% CI for knee osteoarthritis (OA) 
between the model and the meta-analyses of cohort studies from 
literature 
 
 OR (95% CI) 
 Model 1  Literature* 
BMI (kg/m 2 )
 Normal (<25) 1 1
 Overweight (25–29.9) 1.29 (0.71 to 2.33) 1.94 (1.63 to 2.31)
 Obese (≥30) 1.88 (1.20 to 2.96) 3.17 (2.40 to 4.19)
Occupational risk 1.35 (1.05 to 1.73) 1.45 (1.16 to 1.81)
Knee injury 1.96 (0.98 to 3.92) 3.15 (1.52 to 6.52)
 * Three independent meta-analyses for body mass index (BMI), occupational risk and 
knee injury were undertaken and the details will be reported elsewhere. 
 Table 5 Population attributable risks for knee osteoarthritis (OA) 
associated with obesity (BMI >30 kg/m 2 ) 
 Country 
 Prevalence of 
obesity * 
 Radiographic KOA 
PAR% (95% CI) 
 Symptomatic KOA 
PAR% (95% CI) 
USA 33.8 44.4 (37.0 to 51.4) 50.2 (37.4 to 61.4)
Australia 24.8 36.9 (30.1 to 43.7) 42.5 (30.5 to 53.9)
UK: England 24.5 † 36.6 (29.9 to 43.4) 42.2 (30.2 to 53.6)
Germany 20.8 32.9 (26.6 to 39.4) 38.3 (26.9 to 49.5)
Norway 18.3 30.1 (24.1 to 36.4) 35.2 (24.4 to 46.2)
Morocco 15.0 26.1 (20.6 to 31.9) 30.8 (20.9 to 41.3)
Spain 14.6 25.6 (20.3 to 31.4) 30.3 (20.5 to 40.7)
Finland 14.2 25.1 (19.8 to 30.8) 29.7 (20.1 to 40.1)
Sweden 12.9 23.3 (18.3 to 28.8) 27.8 (18.6 to 37.8)
Netherlands 10.3 19.5 (15.1 to 24.3) 23.4 (15.4 to 32.6)
Thailand 6.9 14.0 (10.7 to 17.8) 17.1 (10.9 to 24.5)
China 2.9 6.4 (4.8 to 8.3) 8.0 (4.9 to 12.0)
 * Prevalence estimates obtained from International Obesity Task Force. 29 
 † Average obesity prevalence from England. 
 BMI, body mass index; KOA, knee osteoarthritis, PAR%, population attributable risk 
percentage. 
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of these risk factors, for example, via protection of knees from 
the exposures, is a challenge in practice. 
 In conclusion, we have developed and validated three con-
ventional risk prediction models for the development and pro-
gression of knee OA based on a 12-year retrospective cohort 
study. It is our hope that these models are not to be used as 
gold standards for knee OA prediction, but as pilots to lead 
further research in this area. The models may be applied at 
the individual level to predict the risk, and to encourage risk 
reduction. They may also be used at the population level, 
with reference to other relative risks from published studies, 
to estimate the potential population risk reduction that may 
be gained by primary prevention of the major risk factors of 
knee OA. 
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 Figure 1 Receiver operating characteristic (ROC) curves for radiographic (model 1) and symptomatic (model 2) knee osteoarthritis (OA). Areas 
under the ROC curve and 95% CIs were 0.69 (0.62 to 0.76) and 0.70 (0.61 to 0.79) in the Nottingham knee OA retrospective cohort (internal), 0.60 
(0.55 to 0.64) and 0.60 (0.58 to 0.63) in the Osteoarthritis Initiative (OAI) population, and 0.74 (0.72 to 0.76) and 0.79 (0.77 to 0.81) in the Genetics of 
Osteoarthritis and Lifestyle (GOAL) study. The grey line indicates level of prediction by chance alone.  
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